메뉴 건너뛰기




Volumn 16, Issue 2, 2000, Pages 103-106

Therapeutic guidelines for Pseudomonas aeruginosa infections

Author keywords

Enzymes; Pathogen; Pseudomonas aeruginosa; Resistance; Toxins

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZTREONAM; CARBENICILLIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; TICARCILLIN; TOBRAMYCIN;

EID: 0033774076     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00212-0     Document Type: Article
Times cited : (48)

References (11)
  • 1
    • 0007517651 scopus 로고    scopus 로고
    • Pollack M, Pseudomonas aeruginosa, In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone, 1995. p. 1980-2003.
  • 3
    • 0032860520 scopus 로고    scopus 로고
    • Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program
    • (1999) CID , vol.29 , pp. 595-607
    • Diekema, D.J.1    Pfaller, M.A.2    Jones, R.N.3
  • 5
    • 0007516451 scopus 로고    scopus 로고
    • Jarlier V, Fosse T, Phillippon A, ICU Study Group. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive case units in 39 French teaching hospitals (ICU Study), Int. Care Med. 1996;22:1057-1065.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.